|

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

RECRUITINGPhase 3Sponsored by The Netherlands Cancer Institute
Actively Recruiting
PhasePhase 3
SponsorThe Netherlands Cancer Institute
Started2020-01-01
Est. completion2025-04-01
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT03772028

Summary

stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* candidate for primary CRS
* histological or cytological proven FIGO stage III primary epithelial ovarian, fallopian tube, or extra-ovarian cancer

Exclusion Criteria:

* history of previous malignancies within 5 years prior to inclusion
* FIGO stage IV disease
* complete primary cytoreduction is impossible
* prior treatment for the current malignancy

Conditions2

CancerOvarian Cancer

Locations2 sites

California

1 site
City of Hope
Duarte, California, 91010
Thanh Dellinger, MD626-256-4673

New York

1 site
MSKCC New York
New York, New York, 10065
Bhavani Rameshrameshb@mskcc.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.